A Phase I Study of Lenalidomide Plus a Next Generation Anti-CD20 Antibody, Obinutuzumab, in Relapsed Indolent Lymphoma

Nathan H. Fowler, Raisa M. Pinto, Chan Yoon Cheah, Sattva S. Neelapu, Francesco Turturro, Fredrick B. Hagemeister, Jorge E. Romaguera, Michelle A Fanale, Luis E. Fayad, Sheryl G. Forbes, Janine Khan, Lei Feng, Felipe Samaniego, Loretta J. Nastoupil

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Number of pages3
JournalBlood
Volume126
Issue number23
Publication statusPublished - 3 Dec 2015
Externally publishedYes
Event57th Annual Meeting of the American-Society-of-Hematology - Orlando, United States
Duration: 5 Dec 20158 Dec 2015

Cite this

Fowler, N. H., Pinto, R. M., Cheah, C. Y., Neelapu, S. S., Turturro, F., Hagemeister, F. B., ... Nastoupil, L. J. (2015). A Phase I Study of Lenalidomide Plus a Next Generation Anti-CD20 Antibody, Obinutuzumab, in Relapsed Indolent Lymphoma. Blood, 126(23).
Fowler, Nathan H. ; Pinto, Raisa M. ; Cheah, Chan Yoon ; Neelapu, Sattva S. ; Turturro, Francesco ; Hagemeister, Fredrick B. ; Romaguera, Jorge E. ; Fanale, Michelle A ; Fayad, Luis E. ; Forbes, Sheryl G. ; Khan, Janine ; Feng, Lei ; Samaniego, Felipe ; Nastoupil, Loretta J. / A Phase I Study of Lenalidomide Plus a Next Generation Anti-CD20 Antibody, Obinutuzumab, in Relapsed Indolent Lymphoma. In: Blood. 2015 ; Vol. 126, No. 23.
@article{5fd2e730bc0f481f9e1a23dc34c73d74,
title = "A Phase I Study of Lenalidomide Plus a Next Generation Anti-CD20 Antibody, Obinutuzumab, in Relapsed Indolent Lymphoma",
author = "Fowler, {Nathan H.} and Pinto, {Raisa M.} and Cheah, {Chan Yoon} and Neelapu, {Sattva S.} and Francesco Turturro and Hagemeister, {Fredrick B.} and Romaguera, {Jorge E.} and Fanale, {Michelle A} and Fayad, {Luis E.} and Forbes, {Sheryl G.} and Janine Khan and Lei Feng and Felipe Samaniego and Nastoupil, {Loretta J.}",
year = "2015",
month = "12",
day = "3",
language = "English",
volume = "126",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "23",

}

Fowler, NH, Pinto, RM, Cheah, CY, Neelapu, SS, Turturro, F, Hagemeister, FB, Romaguera, JE, Fanale, MA, Fayad, LE, Forbes, SG, Khan, J, Feng, L, Samaniego, F & Nastoupil, LJ 2015, 'A Phase I Study of Lenalidomide Plus a Next Generation Anti-CD20 Antibody, Obinutuzumab, in Relapsed Indolent Lymphoma' Blood, vol. 126, no. 23.

A Phase I Study of Lenalidomide Plus a Next Generation Anti-CD20 Antibody, Obinutuzumab, in Relapsed Indolent Lymphoma. / Fowler, Nathan H.; Pinto, Raisa M.; Cheah, Chan Yoon; Neelapu, Sattva S.; Turturro, Francesco; Hagemeister, Fredrick B.; Romaguera, Jorge E.; Fanale, Michelle A; Fayad, Luis E.; Forbes, Sheryl G.; Khan, Janine; Feng, Lei; Samaniego, Felipe; Nastoupil, Loretta J.

In: Blood, Vol. 126, No. 23, 03.12.2015.

Research output: Contribution to journalAbstract/Meeting Abstract

TY - JOUR

T1 - A Phase I Study of Lenalidomide Plus a Next Generation Anti-CD20 Antibody, Obinutuzumab, in Relapsed Indolent Lymphoma

AU - Fowler, Nathan H.

AU - Pinto, Raisa M.

AU - Cheah, Chan Yoon

AU - Neelapu, Sattva S.

AU - Turturro, Francesco

AU - Hagemeister, Fredrick B.

AU - Romaguera, Jorge E.

AU - Fanale, Michelle A

AU - Fayad, Luis E.

AU - Forbes, Sheryl G.

AU - Khan, Janine

AU - Feng, Lei

AU - Samaniego, Felipe

AU - Nastoupil, Loretta J.

PY - 2015/12/3

Y1 - 2015/12/3

UR - https://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=21&SID=R19ydIjG31ygg841eR8&page=1&doc=1

M3 - Abstract/Meeting Abstract

VL - 126

JO - Blood

JF - Blood

SN - 0006-4971

IS - 23

ER -

Fowler NH, Pinto RM, Cheah CY, Neelapu SS, Turturro F, Hagemeister FB et al. A Phase I Study of Lenalidomide Plus a Next Generation Anti-CD20 Antibody, Obinutuzumab, in Relapsed Indolent Lymphoma. Blood. 2015 Dec 3;126(23).